Huntsman (HUN) | Financial Analysis & Statements
Huntsman Corporation Mid-cap Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Sep 2025Income Metrics
Revenue
1.5B
Gross Profit
204.0M
13.97%
Operating Income
18.0M
1.23%
Net Income
-11.0M
-0.75%
EPS (Diluted)
$-0.14
Balance Sheet Metrics
Total Assets
7.2B
Total Liabilities
4.1B
Shareholders Equity
3.2B
Debt to Equity
1.28
Cash Flow Metrics
Operating Cash Flow
140.0M
Free Cash Flow
153.0M
Revenue & Profitability Trend
Quarter Income Flow
Sep 30, 2025
Annual Income Flow
2024
Huntsman Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 6.0B | 6.1B | 8.0B | 7.7B | 6.0B |
| Cost of Goods Sold | 5.2B | 5.2B | 6.5B | 6.1B | 4.9B |
| Gross Profit | 866.0M | 906.0M | 1.5B | 1.6B | 1.1B |
| Gross Margin % | 14.3% | 14.8% | 19.3% | 20.7% | 18.3% |
| Operating Expenses | |||||
| Research & Development | 121.0M | 115.0M | 125.0M | 135.0M | 135.0M |
| Selling, General & Administrative | 671.0M | 689.0M | 711.0M | 739.0M | 775.0M |
| Other Operating Expenses | 1.0M | - | -48.0M | -33.0M | -45.0M |
| Total Operating Expenses | 793.0M | 804.0M | 788.0M | 841.0M | 865.0M |
| Operating Income | 73.0M | 102.0M | 758.0M | 743.0M | 235.0M |
| Operating Margin % | 1.2% | 1.7% | 9.4% | 9.7% | 3.9% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 79.0M | 65.0M | 62.0M | 67.0M | 86.0M |
| Other Non-Operating Income | -33.0M | 62.0M | 1.0M | 570.0M | 188.0M |
| Pre-tax Income | -39.0M | 99.0M | 697.0M | 1.2B | 337.0M |
| Income Tax | 61.0M | 64.0M | 186.0M | 191.0M | 46.0M |
| Effective Tax Rate % | 0.0% | 64.6% | 26.7% | 15.3% | 13.6% |
| Net Income | -127.0M | 153.0M | 523.0M | 1.1B | 1.1B |
| Net Margin % | -2.1% | 2.5% | 6.5% | 14.4% | 17.7% |
| Key Metrics | |||||
| EBITDA | 427.0M | 465.0M | 1.1B | 1.2B | 596.0M |
| EPS (Basic) | $-1.10 | $0.57 | $2.29 | $4.77 | $4.69 |
| EPS (Diluted) | $-1.10 | $0.57 | $2.27 | $4.72 | $4.66 |
| Basic Shares Outstanding | 172000000 | 177000000 | 201000000 | 219000000 | 221000000 |
| Diluted Shares Outstanding | 172000000 | 177000000 | 201000000 | 219000000 | 221000000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Huntsman Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 340.0M | 540.0M | 654.0M | 1.0B | 1.6B |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 725.0M | 753.0M | 834.0M | 1.0B | 910.0M |
| Inventory | 917.0M | 867.0M | 995.0M | 1.0B | 848.0M |
| Other Current Assets | 29.0M | 154.0M | 190.0M | 155.0M | 217.0M |
| Total Current Assets | 2.1B | 2.3B | 3.1B | 3.9B | 3.6B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 382.0M | 366.0M | 374.0M | 381.0M | 445.0M |
| Goodwill | 1.6B | 1.7B | 1.7B | 1.8B | 1.5B |
| Intangible Assets | 344.0M | 387.0M | 425.0M | 469.0M | 453.0M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 791.0M | 723.0M | 833.0M | 1.1B | 836.0M |
| Total Non-Current Assets | 5.0B | 4.9B | 5.1B | 5.5B | 5.1B |
| Total Assets | 7.1B | 7.2B | 8.2B | 9.4B | 8.7B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 770.0M | 719.0M | 961.0M | 1.1B | 876.0M |
| Short-term Debt | 379.0M | 58.0M | 117.0M | 61.0M | 645.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | 194.0M | 163.0M | 3.0M |
| Total Current Liabilities | 1.6B | 1.2B | 1.7B | 2.1B | 2.0B |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.9B | 2.0B | 2.0B | 1.9B | 1.9B |
| Deferred Tax Liabilities | 204.0M | 243.0M | 250.0M | 161.0M | 212.0M |
| Other Non-Current Liabilities | 70.0M | 89.0M | 159.0M | 167.0M | 127.0M |
| Total Non-Current Liabilities | 2.4B | 2.6B | 2.7B | 2.8B | 3.1B |
| Total Liabilities | 4.0B | 3.8B | 4.4B | 4.8B | 5.0B |
| Equity | |||||
| Common Stock | 3.0M | 3.0M | 3.0M | 3.0M | 3.0M |
| Retained Earnings | 2.2B | 2.6B | 2.7B | 2.4B | 1.6B |
| Treasury Stock | 2.3B | 2.3B | 1.9B | 934.0M | 731.0M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 3.2B | 3.5B | 3.8B | 4.6B | 3.7B |
| Key Metrics | |||||
| Total Debt | 2.2B | 2.1B | 2.1B | 1.9B | 2.6B |
| Working Capital | 560.0M | 1.1B | 1.4B | 1.9B | 1.6B |
Balance Sheet Composition
Huntsman Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -100.0M | 35.0M | 511.0M | 1.1B | 291.0M |
| Depreciation & Amortization | 289.0M | 278.0M | 281.0M | 278.0M | 283.0M |
| Stock-Based Compensation | 30.0M | 28.0M | 29.0M | 30.0M | 27.0M |
| Working Capital Changes | -119.0M | -128.0M | 240.0M | -717.0M | -214.0M |
| Operating Cash Flow | 281.0M | 360.0M | 1.3B | 735.0M | 656.0M |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | 46.0M | 544.0M | 0 | -202.0M | 1.6B |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | 0 | 0 |
| Investing Cash Flow | 58.0M | 539.0M | 12.0M | -182.0M | 1.7B |
| Financing Activities | |||||
| Share Repurchases | -4.0M | -349.0M | -1.0B | -200.0M | -96.0M |
| Dividends Paid | -174.0M | -169.0M | -171.0M | -159.0M | -144.0M |
| Debt Issuance | 349.0M | 0 | 0 | 447.0M | 0 |
| Debt Repayment | -400.0M | -11.0M | -12.0M | -990.0M | -365.0M |
| Financing Cash Flow | -321.0M | -610.0M | -980.0M | -970.0M | -959.0M |
| Free Cash Flow | 79.0M | -21.0M | 642.0M | 626.0M | 4.0M |
| Net Change in Cash | 18.0M | 289.0M | 283.0M | -417.0M | 1.4B |
Cash Flow Trend
Huntsman Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
46.18
Forward P/E
103.96
Price to Book
0.86
Price to Sales
0.42
PEG Ratio
-1.46
Profitability Ratios
Profit Margin
-5.00%
Operating Margin
-3.40%
Return on Equity
-7.12%
Return on Assets
-0.06%
Financial Health
Current Ratio
1.30
Debt to Equity
81.20
Beta
0.60
Per Share Data
EPS (TTM)
$-1.59
Book Value per Share
$15.93
Revenue per Share
$32.93
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| HUN | 2.4B | 46.18 | 0.86 | -7.12% | -5.00% | 81.20 |
| Dow | 27.9B | 75.93 | 1.73 | -15.26% | -7.24% | 117.10 |
| Celanese | 7.3B | 6.78 | 1.77 | -22.52% | -12.21% | 289.22 |
| Methanex | 4.7B | 64.91 | 1.91 | 5.67% | 2.22% | 128.66 |
| Olin | 3.0B | 43.76 | 1.62 | -5.15% | -1.48% | 167.83 |
| Tronox Holdings plc | 1.6B | 3.87 | 1.06 | -29.20% | -16.22% | 237.54 |
Financial data is updated regularly. All figures are in the company's reporting currency.






